<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04056767</url>
  </required_header>
  <id_info>
    <org_study_id>6269-19-SMC</org_study_id>
    <nct_id>NCT04056767</nct_id>
  </id_info>
  <brief_title>Changes in Digital Phenotype During PE Therapy</brief_title>
  <official_title>Measurement of Changes in the Digital Phenotype During Prolonged Exposure Therapy for PTSD Using Smart Watch</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nadav Goldental</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Chaim Sheba Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      PTSD is characterized by physiological changes, some of which are thought to be chronic,
      while others are observed in response to stressogenic stimuli. Prolonged Exposure (PE)
      therapy is a widely used protocol considered highly affective among individuals diagnosed
      with PTSD.

      The current study is a non-interventional observational study, aimed at measuring changes in
      the digital phenotype of participants with PTSD during and following PE therapy.
      Physiological data will be collected using wearable sensors during the sessions, and
      participants will be assessed using questionnaires and psychiatric assessments before and
      after the completion of their imaginal or writing based PE therapy (10-15 sessions).
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in Heart Rate</measure>
    <time_frame>3 months</time_frame>
    <description>Heart Rate and HRV (Heart Rate Variability)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in Saturation</measure>
    <time_frame>3 months</time_frame>
    <description>Changes in saturation SPO2 (oxygen saturation by pulse oximetry)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in blood pressure</measure>
    <time_frame>3 months</time_frame>
    <description>Changes in Continuous Blood Pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in Pulse Pressure</measure>
    <time_frame>3 months</time_frame>
    <description>Changes in Pulse Pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in Respiratory rate</measure>
    <time_frame>3 months</time_frame>
    <description>Changes in Respiratory rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in Stroke Volume</measure>
    <time_frame>3 months</time_frame>
    <description>Changes in Stroke Volume</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in Systemic Vascular Resistance</measure>
    <time_frame>3 months</time_frame>
    <description>Changes in Systemic Vascular Resistance</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in sweat</measure>
    <time_frame>3 months</time_frame>
    <description>Changes in Sweat</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in Body Temperature</measure>
    <time_frame>3 months</time_frame>
    <description>Changes in Body Temperature</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in Cardiac Output</measure>
    <time_frame>3 months</time_frame>
    <description>Changes in Cardiac Output</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation between changes in digital phenotype (multiple measures)</measure>
    <time_frame>3 months</time_frame>
    <description>Correlation between changes in digital phenotype during the sessions and the clinical improvement according to the psychiatric evaluation and questionnaires.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>PTSD</condition>
  <arm_group>
    <arm_group_label>Imaginal PE</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Writing PE</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adult (aged 18 and over) participants diagnosed with PTSD and undergoing PE therapy; 50
        using imaginal PE and 50 using writing PE.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  PTSD diagnosis

          -  Proper ability to give informed consent

        Exclusion Criteria:

          -  Active psychotic or suicidal symptoms

          -  Severe dissociative symptoms

          -  A traumatic brain injury (TBI) diagnosis

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 6, 2019</study_first_submitted>
  <study_first_submitted_qc>August 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2019</study_first_posted>
  <last_update_submitted>August 13, 2019</last_update_submitted>
  <last_update_submitted_qc>August 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>The Chaim Sheba Medical Center</investigator_affiliation>
    <investigator_full_name>Nadav Goldental</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

